How I treat multiple myeloma in younger patients
作者： A. Keith Stewart , Paul G. Richardson , Jesus F. San-Miguel
DOI: 10.1182/BLOOD-2009-07-204651
关键词: Combined Modality Therapy 、 Maintenance therapy 、 Bortezomib 、 Lenalidomide 、 Surgery 、 Autologous stem-cell transplantation 、 Combination therapy 、 Transplantation 、 Intensive care medicine 、 Medicine 、 Multiple myeloma
摘要: … promising results of Total Therapy 3 (TT3), 4 using all active agents early in treatment, bode well and we think are probably reproduced using the 3- or 4-drug cocktails described above. …
ashpublications.org
elsevier.com
bloodjournal.org参考文章(77)
S. V. Rajkumar, S. Jacobus, N. Callander, R. Fonseca, D. Vesole, M. Williams, R. Abonour, D. Siegel, P. Greipp, Phase III trial of lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone in newly diagnosed multiple myeloma (E4A03): A trial coordinated by the Eastern Cooperative Oncology Group Journal of Clinical Oncology. ,vol. 25, ,(2007) , 10.1200/JCO.2007.25.18_SUPPL.LBA8025
H. Miles Prince, Kevin Imrie, D. Robert Sutherland, Armand Keating, Jacinta Meharchand, R. Michael Crump, Caroline Girouard, Kathy Trip, A. Keith Stewart, Peripheral blood progenitor cell collections in multiple myeloma: Predictors and management of inadequate collections British Journal of Haematology. ,vol. 93, pp. 142- 145 ,(1996) , 10.1046/J.1365-2141.1996.448987.X
Bart Barlogie, Guido J. Tricot, Frits van Rhee, Edguardo Angtuaco, Ron Walker, Joshua Epstein, John D. Shaughnessy, Sundar Jagannath, Vanessa Bolejack, Jennifer Gurley, Antje Hoering, David Vesole, Raman Desikan, David Siegel, Jayesh Mehta, Seema Singhal, Nikhil C. Munshi, Madhav Dhodapkar, Bonnie Jenkins, Michel Attal, Jean-Luc Harousseau, John Crowley, Long-term outcome results of the first tandem autotransplant trial for multiple myeloma British Journal of Haematology. ,vol. 135, pp. 158- 164 ,(2006) , 10.1111/J.1365-2141.2006.06271.X
Robert A. Kyle, Ellen D. Remstein, Terry M. Therneau, Angela Dispenzieri, Paul J. Kurtin, Janice M. Hodnefield, Dirk R. Larson, Matthew F. Plevak, Diane F. Jelinek, Rafael Fonseca, Lee Joseph Melton, S. Vincent Rajkumar, Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. The New England Journal of Medicine. ,vol. 356, pp. 2582- 2590 ,(2007) , 10.1056/NEJMOA070389
Daniel Nowak, Seishi Ogawa, Markus Müschen, Motohiro Kato, Norihiko Kawamata, Antonie Meixel, Verena Nowak, Han S. Kim, Sharon Kang, Ronald Paquette, Mi-Sook Chang, Nils H. Thoennissen, Max Mossner, Wolf-Karsten Hofmann, Alexander Kohlmann, Tamara Weiss, Torsten Haferlach, Claudia Haferlach, H. Phillip Koeffler, SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations. Blood. ,vol. 115, pp. 1049- 1053 ,(2010) , 10.1182/BLOOD-2009-03-210377
Bart Barlogie, Elias Anaissie, Jeffrey Haessler, Fritz Van Rhee, Mauricio Pineda‐Roman, Klaus Hollmig, Yazan Alsayed, Joshua Epstein, John D Shaughnessy Jr, John Crowley, None, Complete remission sustained 3 years from treatment initiation is a powerful surrogate for extended survival in multiple myeloma Cancer. ,vol. 113, pp. 355- 359 ,(2008) , 10.1002/CNCR.23546
Mauricio Pineda-Roman, Vanessa Bolejack, Varant Arzoumanian, Elias Anaissie, Frits van Rhee, Maurizio Zangari, Ron Walker, Klaus Hollmig, John D. Shaughnessy, Joshua Epstein, Somashekar Krishna, John Crowley, Bart Barlogie, Complete response in myeloma extends survival without, but not with history of prior monoclonal gammopathy of undetermined significance or smouldering disease. British Journal of Haematology. ,vol. 136, pp. 393- 399 ,(2007) , 10.1111/J.1365-2141.2006.06441.X
Michel Attal, Jean-Luc Harousseau, Thierry Facon, François Guilhot, Chantal Doyen, Jean-Gabriel Fuzibet, Mathieu Monconduit, Cyrille Hulin, Denis Caillot, Reda Bouabdallah, Laurent Voillat, Jean-Jacques Sotto, Bernard Grosbois, Regis Bataille, Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma New England Journal of Medicine. ,vol. 349, pp. 2495- 2502 ,(2003) , 10.1056/NEJMOA032290
H Paripati, A K Stewart, S Cabou, A Dueck, V J Zepeda, N Pirooz, C Ehlenbeck, C Reeder, J Slack, J F Leis, J Boesiger, A S Torloni, R Fonseca, P L Bergsagel, Compromised stem cell mobilization following induction therapy with lenalidomide in myeloma Leukemia. ,vol. 22, pp. 1282- 1284 ,(2008) , 10.1038/SJ.LEU.2405100
A K Stewart, P L Bergsagel, P R Greipp, A Dispenzieri, M A Gertz, S R Hayman, S Kumar, M Q Lacy, J A Lust, S J Russell, T E Witzig, S R Zeldenrust, D Dingli, C B Reeder, V Roy, R A Kyle, S V Rajkumar, R Fonseca, A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy Leukemia. ,vol. 21, pp. 529- 534 ,(2007) , 10.1038/SJ.LEU.2404516